Author

S.K. Danoff

Observed names: S K Danoff, S. Danoff, SK Danoff

Institutions: Johns Hopkins University, Johns Hopkins Medicine

Observed institutions: Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Bayview Medical Center, Johns Hopkins Hospital

OpenAlex ID: A5035338123

Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease

2021 · JA Huapaya, KD Wiley, et al. · Current Treatment Options in Rheumatology · 2

Clinical Characteristics and Outcomes of Patients With Pulmonary Fibrosis and ANCA Positivity

2025 · S.-A. Whittaker Brown, J. Dickerson, et al. · American Journal of Respiratory and Critical Care Medicine · 1

Diagnostic Delays in Interstitial Lung Diseases (ILDs)

2019 · M. Wijsenbeek, N. Deparis, et al. · 1

B95-03 Effect of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) by Baseline Forced Vital Capacity: Subgroup Analyses of the FIBRONEER Trials

2026 · S K Danoff, A Adegunsoye, et al. · American Journal of Respiratory and Critical Care Medicine

C105-09 No Safe Subtype: Survival After Acute Respiratory Failure in Interstitial Lung Disease

2026 · R Sood, H Lee, et al. · American Journal of Respiratory and Critical Care Medicine

D16-06 Metabolomic Profiling Differentiates PAH-like and ILD-like Phenotypes in Interstitial Lung Disease-related Pulmonary Hypertension

2026 · S L Khan, M R Lammi, et al. · American Journal of Respiratory and Critical Care Medicine

Patients With Connective Tissue Disease-related Interstitial Lung Disease and Pulmonary Hypertension With a Parenchymal Phenotype Have Worse Clinical Outcomes Compared to Those With a Vascular Phenotype

2025 · S.L. Khan, K.J. Psoter, et al. · American Journal of Respiratory and Critical Care Medicine

Systematic Use of Chest Imaging and Spirometry to Distinguish Phenotypes of Pulmonary Hypertension in Patients With Connective Tissue Disease-related Interstitial Lung Disease

2023 · S.L. Khan, K.J. Psoter, et al.

A Systematic Review and Meta-Analysis of Anti-Ro52 Antibodies in Interstitial Lung Disease Associated with Connective Tissue Disease

2022 · J.A. Huapaya, M. Zhao, et al.

Baseline Characteristics of Participants in the Treatment for Rheumatoid Arthritis and Interstitial Lung Disease 1 (TRAIL1) Trial

2021 · J. Solomon, S.K. Danoff, et al.

Myositis-Associated Interstitial Lung Disease

2021 · J.A. Huapaya, S.K. Danoff · Elsevier eBooks

OP0038 Myositis autoantibodies outperform clinical subgroup classification in predicting muscle weakness in myositis patients

2017 · I Pinal-Fernandez, W Huang, et al. · Annals of the Rheumatic Diseases

OP0010 Thigh Magnetic Resonance Imaging Reveals Increased Active and Chronic Muscle Damage in Necrotizing Myositis Compared To Polymyositis and Dermatomyositis

2016 · I. Pinal-Fernandez, M. Casal-Dominguez, et al. · Annals of the Rheumatic Diseases

FRI0273 Slow Recovery of Muscle Strength in Young Anti-HMG-COA Reductase Positive Myopathy Patients

2016 · E. Tiniakou, I. Pinal Fernandez, et al. · Annals of the Rheumatic Diseases

A Mouse Model of Spontaneous Emphysema.

2009 · SK Danoff, D Sharma, et al.

Clinical, Radiographic, and Pathologic Variation in Antisynthetase Syndrome.

2009 · GR Connors, B Richardson, et al.

Works count: 16

Citation count: 4

H-index: 1

I10-index: